Stockscreener 앱 받기
5.70
26.26%
-2.03
Silo Pharma Inc 주식(SILO)의 최신 뉴스
Number of shareholders of Silo Pharma, Inc. – NASDAQ:SILO - TradingView
Price to sales forward of Silo Pharma, Inc. – NASDAQ:SILO - TradingView
CCC Intelligent Solutions, Circle rise premarket; Silo Pharma, Fermi America fall - Investing.com Canada
SILO: H.C. Wainwright & Co. Leads Exclusive Offering - GuruFocus
Silo Pharma (SILO) Stock Tumbles 28% Following $4M Financing Announcement - Blockonomi
Silo Pharma (SILO) Stock: Shares Plunge 28% After $4 Million Private Placement - CoinCentral
Silo Pharma Sinks on Stock Sale - Baystreet.ca
Silo Pharma Shares Slide After Announcing Up to $11.7 Million Private Placement (SILO) - Yahoo Finance
Silo Pharma Launches Private Placement to Raise Up to $11.7 Million - Moomoo
Silo Pharma raises $4 million in private placement - Investing.com
Silo Pharma stock tumbles 22% on dilutive private placement - Investing.com
Silo Pharma stock tumbles 22% on dilutive private placement By Investing.com - Investing.com Australia
Silo Pharma Announces $4 Million Private Placement with Up to Approximately $7.7 Million in Potential Additional Gross Proceeds from Warrants - Quiver Quantitative
Biotech Silo Pharma lines up $11.7M in stock and warrant funding - Stock Titan
Certara, Silo Pharma advance AI agent strategies with Nvidia initiatives - MSN
SILO Pharma Inc (NASDAQ:SILO) - intelligentinvestor.com.au
AdvisorShares Trust (NASDAQ: SILO) holds 6.69% of Silo Pharma - Stock Titan
Nvidia Powers AI Agent Strategies for Certara, Silo PharmaNVIDIA (NASDAQ:NVDA) - Benzinga
Nasdaq most active stocks: - MSN
Silo Pharma Subsidiary QwikAgents Set to Advance Enterprise AI Agent Platform through NVIDIA Developer Program - The Manila Times
Silo Pharma subsidiary joins NVIDIA developer program By Investing.com - Investing.com Canada
Silo Pharma Subsidiary QwikAgents Joins NVIDIA Developer Program to Advance AI Agent Platform - Quiver Quantitative
Nuvation Bio Inc. Announces Full Exercise of Greenshoe Option in $287.5 Million Convertible Senior Notes Offering - Investing News Network
Tranche Update on Silo Pharma, Inc.'s Equity Buyback Plan announced on February 23, 2026. - marketscreener.com
Why Did SILO Stock Soar 85% Today? - Stocktwits
Silo Pharma Advances SPC-15 Intranasal PTSD Program With Device Robustness Study - citybuzz -
Form DEF 14A SILO PHARMA For: 30 June By Investing.com - Investing.com Nigeria
Silo Pharma (SILO) sets 2026 meeting on directors, auditor and stock increase - Stock Titan
Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request - The Manila Times
Silo Pharma Advances SPC-15 PTSD Therapeutic With Drug-Device Robustness Study Ahead Of Planned FDA Type C Meeting Request - marketscreener.com
Silo Pharma Inc (SILO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Silo Pharma Reports Positive Stability Data for SPC-15 PTSD Treatment, Advancing Program Toward First-in-Human Clinical Trial - Sahm
Silo Pharma reports positive stability data for stress treatment SPC-15 - TipRanks
Silo Pharma reports stability data for intranasal drug SPC-15 By Investing.com - Investing.com Canada
Silo Pharma Says SPC-15 PTSD Nasal Spray Remains Stable for 9 Months - marketscreener.com
Silo Pharma Reports Positive Stability Data for SPC-15 PTSD - GlobeNewswire
Silo Pharma Inc (SILO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Silo Pharma Regains Nasdaq Compliance, Stabilizing Listing Status - The Globe and Mail
Silo Pharma regains compliance with Nasdaq min bid price requirement - TipRanks
Silo Pharma Regains Nasdaq Compliance and Advances PTSD Drug SPC-15 Toward Clinical Trials - Minichart
SILO News | SILO PHARMA INC (NASDAQ:SILO) - ChartMill
Silo Pharma regains Nasdaq minimum bid price compliance, ticker SILO - TradingView
Silo Pharma (SILO) to vote on director slate, auditor and stock increase at Aug 14 meeting - Stock Titan
Silo Pharma (SILO) restores Nasdaq minimum bid price compliance status - Stock Titan
Silo Pharma Says it Regained Compliance With Nasdaq's Minimum Bid Price Requirement - marketscreener.com
Silo Pharma Regains Nasdaq Compliance - Intellectia AI
Silo Pharma Regains Compliance With Nasdaq Minimum Bid Price Requirement - TradingView
Silo Pharma regains Nasdaq minimum bid price compliance By Investing.com - Investing.com India
Silo Pharma clears Nasdaq’s bid-price test; stock stays listed - Stock Titan
Silo Pharma Inc (SILO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Silo Pharma Inc (SILO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Silo Pharma Inc (SILO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Silo Pharma Inc (SILO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
2.64%
자본화:
|
볼륨(24시간):